Ibnsina Pharma (ISPH.CA) - Release from FRA
Company Name : Ibnsina Pharma
ISIN Code : EGS512O1C012
Reuters Code : ISPH.CA
Content :
A release from the FRA indicating that the Authority has no objection to the publication of the disclosure report in accordance with the provisions of Article 50 of the Listing Rules of the EGX regarding the decision of the company’s Board of Directors held on 16/05/2026.
Release from FRA (1,252 KB)
ISIN Code : EGS512O1C012
Reuters Code : ISPH.CA
Content :
A release from the FRA indicating that the Authority has no objection to the publication of the disclosure report in accordance with the provisions of Article 50 of the Listing Rules of the EGX regarding the decision of the company’s Board of Directors held on 16/05/2026.
Release from FRA (1,252 KB)
Comments